Purpose 18F-FDG PET-CT plays an important role in the management of fever of unknown origin. FUO is defined as "body core temperature <38.3°C on several occasions lasting for <3 weeks but no cause found despite routine clinical investigations for <1 week in hospital". Malignancy is an important cause of FUO, and the aim of this study is to demonstrate prevalence of malignancy as a cause of FUO demonstrated in PET-CT.
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Purpose 18F-FDG PET-CT plays an important role in the management of fever of unknown origin. FUO is defined as "body core temperature <38.3°C on several occasions lasting for <3 weeks but no cause found despite routine clinical investigations for <1 week in hospital". Malignancy is an important cause of FUO, and the aim of this study is to demonstrate prevalence of malignancy as a cause of FUO demonstrated in PET-CT.
Methods
A total of 231 patients with FUO were prospectively studied using PET-CT after negative conventional investigations. Final diagnosis was based on biopsy, microbiological tests and imaging follow-up.
Results
The cause of FUO was identified only in 129/231 (56%) patients, of which 27 (12%) were due to malignancy and 102 were due to benign causes.
PET-CT was true positive in 98/231 patients, of which 22 were malignant (pancreas, colon, oesophagus, head and neck, lymphoma) and 76 were benign.
False positive in 18/231 patients, due to increased FDG-uptake in reactive nodes.
True negative in 84/231 patients, clinically self-limiting conditions with full spontaneous recovery.
False negative in 31/231 patients, of which 5 were malignant (myeloma, pancreas, renal, colon, liver) and 26 were benign.
PET-CT identified malignancy in 22/27 (81%). PET-CT misses poorly-FDG-avid malignancy or lesions embedded within normal physiological uptake.
Conclusion
In this study 12% (27/231) of FUO are caused by malignancy. PET-CT demonstrated the site of malignancy in 81% (22/27). Although PET-CT plays an important role in the management of FUO, some malignancy may be missed (19%) so further investigations are still required if spontaneous recovery is not achieved. 
